Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells

Carboplatin is the most used first-line drug for the treatment of human retinoblastoma (RB), a rare form of cancer in infancy and childhood. However, the clinical application of carboplatin is restricted due to the emergence of acquired multi-drug resistance (MDR) after long-term treatment. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ke, Huang, Jun, Liu, Jiao, Klionsky, Daniel J., Kang, Rui, Tang, Daolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163041/
https://www.ncbi.nlm.nih.gov/pubmed/35654783
http://dx.doi.org/10.1038/s41419-022-04974-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163041/
https://www.ncbi.nlm.nih.gov/pubmed/35654783
http://dx.doi.org/10.1038/s41419-022-04974-8

Ejemplares similares